Pabbaraju Kanti, Wong Sallene, Song Joanna J, Singh Ameeta E, Read Ron, Drews Steven J
Provincial Laboratory for Public Health, Calgary, Alberta, Canada.
J Clin Microbiol. 2013 Dec;51(12):4156-60. doi: 10.1128/JCM.01694-13. Epub 2013 Oct 9.
In our jurisdiction, the Aptima Combo 2 assay (Gen-Probe, Inc.) is used to detect Neisseria gonorrhoeae from specimens collected at clinics for sexually transmitted infections (STI) and from select community patients. In addition, swabs are also collected for N. gonorrhoeae culture, susceptibility testing, and sequence typing (ST). Since only a small proportion of samples from provincial cases undergo culture, the available trends in antimicrobial susceptibility and predominant strain types may not be representative of all N. gonorrhoeae infections. Due to the limitations facing the use of N. gonorrhoeae culture to understand these trends in the general community, we performed a molecular analysis for markers of cephalosporin resistance and ST determination by using nucleic acid extracts of specimens sent for Aptima testing. Thirty-four samples submitted for both Aptima testing and N. gonorrhoeae culture from the same anatomic location (within 24 h) were included in the study. Sequence type was determined based on the sequence of the por and tbpB genes, and amino acid changes in the PBP 2 protein, encoded by the penA gene, were considered representative for the assessment of antimicrobial susceptibility. Sequence identity of 100% was observed between the sequences obtained from Aptima-analyzed samples and culture samples. Sequencing results showed an association between decreased susceptibility to extended-spectrum cephalosporins (ESC(ds)), tbp allele 110, ST 1407, and amino acid changes (G545S, I312M, and V316T) in the PBP 2 protein. Our data, generated based on a few representative genes, suggest that gonococcal samples positive by Aptima testing can be used to determine single nucleotide polymorphisms associated with ESC(ds) and the sequence type based on molecular strain typing. Confirmation of these findings may obviate the need for gonorrhea culture in the future.
在我们的管辖区域,Aptima Combo 2检测法(基因探针公司)用于从性病诊所收集的性传播感染(STI)标本以及部分社区患者的标本中检测淋病奈瑟菌。此外,还采集拭子用于淋病奈瑟菌培养、药敏试验和序列分型(ST)。由于省级病例中只有一小部分样本进行培养,现有的抗菌药物敏感性趋势和主要菌株类型可能无法代表所有淋病奈瑟菌感染情况。鉴于使用淋病奈瑟菌培养来了解普通社区这些趋势存在局限性,我们利用送去进行Aptima检测的标本核酸提取物,对头孢菌素耐药标记物和序列分型进行了分子分析。本研究纳入了34份从相同解剖部位在24小时内送去进行Aptima检测和淋病奈瑟菌培养的样本。根据por和tbpB基因的序列确定序列类型,由penA基因编码的PBP 2蛋白中的氨基酸变化被视为评估抗菌药物敏感性的代表。从Aptima分析样本和培养样本获得的序列之间观察到100%的序列同一性。测序结果显示,对超广谱头孢菌素敏感性降低(ESC(ds))、tbp等位基因110、ST 1407与PBP 2蛋白中的氨基酸变化(G545S、I312M和V316T)之间存在关联。我们基于少数代表性基因生成的数据表明,Aptima检测呈阳性的淋球菌样本可用于确定与ESC(ds)相关的单核苷酸多态性以及基于分子菌株分型的序列类型。这些发现的证实可能会在未来消除淋病培养的必要性。